A simple sample size formula for analysis of covariance in randomized clinical trials
- PMID: 17998077
- DOI: 10.1016/j.jclinepi.2007.02.006
A simple sample size formula for analysis of covariance in randomized clinical trials
Abstract
Objective: Randomized clinical trials that compare two treatments on a continuous outcome can be analyzed using analysis of covariance (ANCOVA) or a t-test approach. We present a method for the sample size calculation when ANCOVA is used.
Study design and setting: We derived an approximate sample size formula. Simulations were used to verify the accuracy of the formula and to improve the approximation for small trials. The sample size calculations are illustrated in a clinical trial in rheumatoid arthritis.
Results: If the correlation between the outcome measured at baseline and at follow-up is rho, ANCOVA comparing groups of (1-rho(2))n subjects has the same power as t-test comparing groups of n subjects. When on the same data, ANCOVA is used instead of t-test, the precision of the treatment estimate is increased, and the length of the confidence interval is reduced by a factor 1-rho(2).
Conclusion: ANCOVA may considerably reduce the number of patients required for a trial.
Similar articles
-
Parametric versus non-parametric statistics in the analysis of randomized trials with non-normally distributed data.BMC Med Res Methodol. 2005 Nov 3;5:35. doi: 10.1186/1471-2288-5-35. BMC Med Res Methodol. 2005. PMID: 16269081 Free PMC article.
-
Sample-size calculations for studies with correlated ordinal outcomes.Stat Med. 2005 Oct 15;24(19):2977-87. doi: 10.1002/sim.2162. Stat Med. 2005. PMID: 16149125
-
Towards an epidemiology of rheumatoid arthritis outcome with respect to treatment: randomized controlled trials overestimate treatment response and effectiveness.Rheumatology (Oxford). 2005 Dec;44 Suppl 4:iv18-iv22. doi: 10.1093/rheumatology/kei056. Rheumatology (Oxford). 2005. PMID: 16306476
-
Most tumour necrosis factor inhibitor trials in rheumatology are undeservedly called 'efficacy and safety' trials: a survey of power considerations.Rheumatology (Oxford). 2008 Jul;47(7):1054-7. doi: 10.1093/rheumatology/ken190. Epub 2008 May 21. Rheumatology (Oxford). 2008. PMID: 18495823 Review.
-
Efficient ways exist to obtain the optimal sample size in clinical trials in rare diseases.J Clin Epidemiol. 2008 Apr;61(4):324-30. doi: 10.1016/j.jclinepi.2007.07.008. Epub 2008 Feb 21. J Clin Epidemiol. 2008. PMID: 18313556 Review.
Cited by
-
Effects of Artificial Aging of Direct Resin Nano-Hybrid Composite on Mean Bond Strength Values for Veneer Ceramic Samples.Med Sci Monit. 2024 Aug 13;30:e945243. doi: 10.12659/MSM.945243. Med Sci Monit. 2024. PMID: 39182170 Free PMC article.
-
Effectiveness of work-related medical rehabilitation in cancer patients: study protocol of a cluster-randomized multicenter trial.BMC Cancer. 2016 Jul 27;16:544. doi: 10.1186/s12885-016-2563-z. BMC Cancer. 2016. PMID: 27465148 Free PMC article. Clinical Trial.
-
Improving quality of life in cancer patients through higher participation and health literacy: study protocol for evaluating the oncological social care project (OSCAR).BMC Health Serv Res. 2019 Oct 26;19(1):754. doi: 10.1186/s12913-019-4585-0. BMC Health Serv Res. 2019. PMID: 31655598 Free PMC article. Clinical Trial.
-
A randomized clinical trial of the effectiveness of mechanical traction for sub-groups of patients with low back pain: study methods and rationale.BMC Musculoskelet Disord. 2010 Apr 30;11:81. doi: 10.1186/1471-2474-11-81. BMC Musculoskelet Disord. 2010. PMID: 20433733 Free PMC article. Clinical Trial.
-
Prednisolone versus placebo addition in the treatment of patients with recent-onset psychotic disorder: a trial design.Trials. 2020 Jun 8;21(1):492. doi: 10.1186/s13063-020-04365-4. Trials. 2020. PMID: 32513294 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical